DexTech: Invitation to open Annual General Meeting and notice
5 October, 2026
On Monday, November 2, 2026, DexTech Medical AB (“DexTech”) will hold its Annual General Meeting. Subject to availability, non-shareholders are also welcome to participate without voting rights. At the meeting, the founders, CEO Anders R Holmberg and Chief Medical Officer Professor Sten Nilsson, will present the company and the current clinical situation regarding prostate cancer and multiple myeloma. There will be an opportunity to ask questions to DexTech’s Board of Directors and management. Formal notice of the Annual General Meeting is available further down in this press release.
Notification for non-shareholders shall be made no later than Friday, October 30, 2026 and may be made by e-mail (gosta.lundgren@dextechmedical.com) or in writing to DexTech Medical AB, Annual General Meeting, Box 389, 751 06 Uppsala, Sweden.
The Annual General Meeting will begin at 10.00 a.m. in IVA’s Conference Centre, Kungl. The Royal Swedish Academy of Engineering Sciences, Grev Turegatan 16, Stockholm. Admission to the Annual General Meeting will commence at 9.30 a.m.
In addition to the above, please note that participation for non-shareholders is subject to formal approval by the Annual General Meeting at the beginning of the Annual General Meeting.
For further information
Gösta Lundgren, CFO
DexTech Medical AB
Phone: +46 (0) 70 710 47 88
E-mail: gosta.lundgren@dextechmedical.com